立体定向放射外科治疗累及海绵窦的颅底肿瘤的长期结局
本研究回顾了1990至2018年在本机构接受立体定向放射外科治疗的113例良性海绵窦肿瘤患者,包括91例脑膜瘤、14例三叉神经鞘瘤和8例海绵状血管瘤。中位随访77个月,全队列5年、10年、15年无进展生存率分别为97%、89%、87%。35例(27%)患者颅神经功能改善,11例(10%)出现颅神经恶化或新发缺损。
要点
- 全队列5年、10年、15年无进展生存率分别为97%、89%、87%。
- 脑膜瘤5年、10年无进展生存率分别为96%、87%,其他肿瘤10年为100%。
- 35例(27%)颅神经功能改善,11例(10%)出现颅神经恶化或新发缺损。
核心结论
- 立体定向放射外科为良性海绵窦肿瘤患者提供了良好的肿瘤控制和可接受的长期结局,并充分保留了颅神经功能。
研究设计与样本
- 回顾性队列研究,纳入1990至2018年在本机构接受立体定向放射外科治疗的113例良性海绵窦肿瘤患者,包括91例脑膜瘤、14例三叉神经鞘瘤和8例海绵状血管瘤。
主要发现
- 中位随访77个月(四分位距39-177个月)。
- 全队列5年、10年、15年无进展生存率分别为97%、89%、87%;脑膜瘤5年、10年分别为96%、87%;其他肿瘤10年为100%。
- 脑膜瘤与非脑膜瘤之间无显著差异(log-rank检验,p=0.107)。
- 35例(27%)患者颅神经功能改善;三叉神经鞘瘤较脑膜瘤更常出现颅神经改善(总改善率62% vs. 23%,p=0.004;眼动功能改善率100% vs. 20%,p=0.002)。
- 11例(10%)患者出现颅神经恶化或新发颅神经缺损。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Stereotactic radiosurgery (SRS) is an effective and less invasive therapeutic option for cavernous sinus (CS) tumors. However, its long-term effectiveness and neurological outcomes have yet to be fully elucidated. We aimed to examine the long-term outcomes of SRS for CS tumors. METHODS: Overall, a cohort of 113 patients with benign CS tumors, including 91 with meningioma, 14 with trigeminal schwannoma (TS), and eight with cavernous hemangioma, treated with SRS at our institution from 1990 to 2018, was included. Tumor control and functional preservation/recovery were evaluated in detail. RESULTS: The median post-SRS follow-up period was 77 months (interquartile range, 39-177). Progression-free survival (PFS) was 97% at 5 years, 89% at 10 years, and 87% at 15 years for the entire cohort; 96% at 5 years and 87% at 10 years for meningiomas; and 100% at 10 years for the other tumors. No significant difference was observed between meningiomas and non-meningiomas (log-rank test, p = 0.107). Improvement in cranial nerve (CN) function was observed in 35 (27%) patients. TSs tended to show CN improvements more often than meningiomas did (total improvements, 62% vs. 23%; p = 0.004; eye movement function, 100% vs. 20%; p = 0.002). CN deterioration or development of new CN deficits was observed in 11 (10%) patients. CONCLUSION: SRS provides good tumor control and acceptable long-term outcome with sufficient preservation of CN function in patients with benign CS tumors.
引用
- Umekawa M, Shinya Y, Hasegawa H, et al. Long-term outcomes of stereotactic radiosurgery for skull base tumors involving the cavernous sinus. J Neurooncol. 2022. PMID: 35028788. doi:10.1007/s11060-021-03921-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。